7498 Results (Page 200 of 300)
Pharmaceuticals Markets Research Reports
Saudi Arabia Alopecia (Hair Loss) Therapeutics Market Analysis
The Saudi Arabia Alopecia (Hair Loss) Therapeutics Market was valued at US $139 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $278 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), growing healthcare infrastructure, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Cipla, Mylan, Theradome, and Pfizer, among others.
Philippines Alopecia (Hair Loss) Therapeutics Market Analysis
The Philippines Alopecia (Hair Loss) Therapeutics Market was valued at US $18 Mn in 2022, and is predicted to grow at (CAGR) of 8% from 2023 to 2030, to US $33 Mn by 2030. The primary factors propelling this industry forward include the notable increase in the prevalence of Alopecia (hair loss), expanding treatment options, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Lexington, Merck, Capillus, and Follica Inc., among others.
Mexico Alopecia (Hair Loss) Therapeutics Market Analysis
The Mexico Alopecia (Hair Loss) Therapeutics Market was valued at US $123 Mn in 2022, and is predicted to grow at (CAGR) of 7.75% from 2023 to 2030, to US $223 Mn by 2030. The key drivers of this industry include the surge in the prevalence of Alopecia (hair loss), increased disposable income, lifestyle changes and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Pfizer, Cipla, Sun Pharmaceuticals, and iRestore, among others
Malaysia Alopecia (Hair Loss) Therapeutics Market Analysis
The Malaysia Alopecia (Hair Loss) Therapeutics Market was valued at US $13 Mn in 2022, and is predicted to grow at (CAGR) of 7.7% from 2023 to 2030, to US $24 Mn by 2030. The primary factors propelling this industry forward include the notable increase in the prevalence of Alopecia (hair loss), technological advancements, and others. The industry is primarily dominated by players such as Johnson & Johnson, Lexington, Sun Pharmaceuticals, Merck, Capillus, Follica Inc., among others
Kenya Alopecia (Hair Loss) Therapeutics Market Analysis
The Kenya Alopecia (Hair Loss) Therapeutics Market was valued at US $6 Mn in 2022, and is predicted to grow at (CAGR) of 8.6% from 2023 to 2030, to US $11 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), the evolving treatment landscape, and others. The industry is primarily dominated by players such as Roche, Johnson & Johnson, Bayer, Sanofi, Lexington, and Merck, among others.
Japan Alopecia (Hair Loss) Therapeutics Market Analysis
The Japan Alopecia (Hair Loss) Therapeutics Market was valued at US $510 Mn in 2022, and is predicted to grow at (CAGR) of 8% from 2023 to 2030, to US $943 Mn by 2030. The primary factors propelling this industry forward include the notable increase in the prevalence of Alopecia (hair loss), technological advancements, and others. The industry is primarily dominated by players such as Johnson & Johnson, Lexington, Sun Pharmaceuticals, Merck, Capillus, and Follica Inc., among others.
Indonesia Alopecia (Hair Loss) Therapeutics Market Analysis
The Indonesia Alopecia (Hair Loss) Therapeutics Market was valued at US $49 Mn in 2022, and is predicted to grow at (CAGR) of 7.50% from 2023 to 2030, to US $88 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), demand for new treatments, demographic shifts, and others. The industry is primarily dominated by players such as Johnson & Johnson, Lexington, Sun Pharmaceuticals, Capillus, and Follica Inc among others.
Germany Alopecia (Hair Loss) Therapeutics Market Analysis
The Germany Alopecia (Hair Loss) Therapeutics Market was valued at US $300 Mn in 2022, and is predicted to grow at (CAGR) of 5.7% from 2023 to 2030, to US $468 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), supportive government initiatives, technological advancements, and others. The industry is primarily dominated by players such as, Eli Lilly, Merck, Pfizer, Bayer, Valeant Pharmaceuticals, and iRestore, among others.
France Alopecia (Hair Loss) Therapeutics Market Analysis
The France Alopecia (Hair Loss) Therapeutics Market was valued at US $226 Mn in 2022, and is predicted to grow at (CAGR) of 6.5% from 2023 to 2030, to US $373 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), increased disposable income, lifestyle changes, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Pfizer, Cipla, Sun Pharmaceuticals, and iRestore, among others.
Egypt Alopecia (Hair Loss) Therapeutics Market Analysis
The Egypt Alopecia (Hair Loss) Therapeutics Market was valued at US $23 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $46 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), improved socioeconomic conditions, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Cirrus, Cipla, Lexington, and Merck, among others.
Canada Alopecia (Hair Loss) Therapeutics Market Analysis
The Canada Alopecia (Hair Loss) Therapeutics Market was valued at US $0.65 Bn in 2022, and is predicted to grow at (CAGR) of 7.50% from 2023 to 2030, to US $1.17 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of Alopecia (hair loss), improved treatment options. The industry is primarily dominated by players such as Eli Lilly, Pfizer, Allergan, Valeant, Bayer, Roche, AbbVie among others.
Brazil Alopecia (Hair Loss) Therapeutics Market Analysis
The Brazil Alopecia (Hair Loss) Therapeutics Market was valued at US $205 Mn in 2022, and is predicted to grow at (CAGR) of 8.5% from 2023 to 2030, to US $394 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), increased disposable income, lifestyle changes, and others. The industry is primarily dominated by players such as Johnson & Johnson, Eli Lilly, Merck, Cipla, Sun Pharmaceuticals, Theradome, and Pfizer, among others.
Vietnam Allergy Therapeutics Market Analysis
Vietnam allergy therapeutics market was valued at $116 Mn in 2022 and is estimated to reach $194 Mn in 2030, exhibiting a CAGR of 6.63% during the forecast period. The demand for allergy treatment drugs is expanding due to the increased prevalence of allergic disorders and associated health problems. The top pharmaceutical companies that are currently operating in the market are GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Bayer, Pfizer, Abbott, Teva Pharmaceutical, DHG Pharma and Boston Pharmaceuticals.
US Allergy Therapeutics Market Analysis
US Allergy Therapeutics Market was valued at $9744 Mn in 2022 and is estimated to reach $13751 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The market for allergy therapeutics is expanding as a result of the rising incidence of allergic illnesses and associated medical conditions. Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer are few leading companies working in the allergy therapeutics market.
UK Allergy Therapeutics Market Analysis
UK allergy therapeutics market was valued at $603 Mn in 2022 and is estimated to reach $851 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The increasing prevalence of allergic disorders and related health problems is driving the demand for allergy therapeutics. The major pharmaceutical companies that are presently performing in the market are GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, Novartis, Pfizer, Sanofi, Merck & Co., Roche, Boehringer Ingelheim and AbbVie.
UAE Allergy Therapeutics Market Analysis
UAE allergy therapeutics market was valued at $116 Mn in 2022 and is estimated to reach $205 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The growing prevalence of allergic disorders and related medical issues is driving growth in the market for allergy treatment drugs. The top leading pharmaceutical companies operating in the market are Sanofi, GlaxoSmithKline (GSK), Novartis, Merck & Co., AstraZeneca, Bayer, Pfizer, Teva Pharmaceutical Industries, Almirall, and Chiesi Farmaceutici.
Spain Allergy Therapeutics Market Analysis
Spain Allergy Therapeutics Market was valued at $448 Mn in 2022 and is estimated to reach $682 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period. The increasing prevalence of allergic disorders and related health problems is driving the demand for allergy therapeutics. The major pharmaceutical companies that are presently performing in the market are Novartis, GlaxoSmithKline (GSK), Sanofi, Roche, Merck & Co., Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim, and Allergan.
South Africa Allergy Therapeutics Market Analysis
South Africa Allergy Therapeutics Market was valued at $151 Mn in 2022 and is estimated to reach $272 Mn in 2030, exhibiting a CAGR of 7.63% during the forecast period. The demand for allergy treatment medications is rising due to the rise in allergic conditions and related medical conditions. GlaxoSmithKline, Sanofi, Novartis, AstraZeneca, Bayer, Aspen Pharmacare, Adcock Ingram, Lupin Ltd., Cipla Medpro, and Pfizer are the top leading pharmaceutical companies that are presently operating in the market.
Singapore Allergy Therapeutics Market Analysis
Singapore Allergy Therapeutics Market was valued at $28 Mn in 2022 and is estimated to reach $48 Mn in 2030, exhibiting a CAGR of 7% during the forecast period. The rising incidence of allergic illnesses and the resulting health issues is fueling the growing demand for allergy therapy medications. The leading pharmaceutical companies that are presently operating in the market are GlaxoSmithKline, Novartis, AstraZeneca, Merck & Co., Sanofi, Pfizer, Johnson & Johnson, Abbott, Bayer and Boehringer Ingelheim.
Saudi Arabia Allergy Therapeutics Market Analysis
Saudi Arabia allergy therapeutics market was valued at $394 Mn in 2022 and is estimated to reach $725 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The market for allergy therapeutics is expanding as a result of the rising incidence of allergic illnesses and associated medical conditions. Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer are few leading companies working in the allergy therapeutics market.
Philippines Allergy Therapeutics Market Analysis
Philippines Allergy Therapeutics Market was valued at $51 Mn in 2022 and is estimated to reach $87 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. The growing demand for allergy therapy drugs is being driven by the rise in the prevalence of allergic disorders and related health problems. The major pharmaceutical players that are presently functioning in the market are GlaxoSmithKline, Novartis, AstraZeneca, Merck & Co., Sanofi, Unilab, Generika Drug Corporation, Delmar Pharmaceuticals, Pfizer and Johnson & Johnson.
Mexico Allergy Therapeutics Market Analysis
Mexico Allergy Therapeutics Market was valued at $348 Mn in 2022 and is estimated to reach $582 Mn in 2030, exhibiting a CAGR of 6.65% during the forecast period. The market for allergy treatment medications is expanding as a result of the rising incidence of allergic illnesses and associated health problems. The top leading pharmaceutical companies operating in the market are GlaxoSmithKline, Sanofi, Merck & Co., Novartis, Bayer, Johnson & Johnson, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Grupo farmacéutico Sanfer and Genomma Laboratorios.
Malaysia Allergy Therapeutics Market Analysis
Malaysia Allergy Therapeutics Market was valued at $37 Mn in 2022 and is estimated to reach $62 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increased incidence of allergic illnesses and associated health issues is driving the need for allergy therapy medications. The major pharmaceutical players that are presently functioning in the market are GlaxoSmithKline, Sanofi, Novartis, Bayer, AstraZeneca, Eisai Co., Takeda Pharmaceutical Company, Pharmaniaga Berhad, Duopharma Biotech Bhd and Reckitt Benckiser.
Kenya Allergy Therapeutics Market Analysis
Kenya Allergy Therapeutics Market was valued at $16 Mn in 2022 and is estimated to reach $29 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The growing numbers of allergic disorders and associated health problems is driving up the need for allergy treatment drugs. GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Bayer, Pfizer, Abbott, Pharmanet Kenya Ltd., Mepharm Kenya Ltd. and Mediheal Kenya Ltd. are top leading pharmaceutical companies that are currently operating in the market.
Japan Allergy Therapeutics Market Analysis
Japan Allergy Therapeutics Market was valued at $1442 Mn in 2022 and is estimated to reach $2459 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. The increased incidence of allergic illnesses and associated health issues is driving the need for allergy therapy medications. The major pharmaceutical players that are presently functioning in the market are Eisai Co., Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi, GlaxoSmithKline (GSK), AstraZeneca, Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Kowa Pharmaceutical Co., and Daiichi Sankyo Co.
